{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T08:23:11Z","timestamp":1761898991281,"version":"build-2065373602"},"reference-count":18,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Genetics"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1016\/j.cancergen.2016.09.007","type":"journal-article","created":{"date-parts":[[2016,9,21]],"date-time":"2016-09-21T03:19:17Z","timestamp":1474427957000},"page":"481-485","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Chronic myelogenous leukemia with acquired t(11;14)(q13;q32) CCND1-IGH: A case report and literature review"],"prefix":"10.1016","volume":"209","author":[{"given":"M.T.","family":"Manda-Mapalo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Khalili","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Quintana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Rabinowitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Q.Y.","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cancergen.2016.09.007_bib0010","series-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","first-page":"32","article-title":"Chronic myelogenous leukemia, BCR-ABL1 positive","author":"Vardiman","year":"2008"},{"key":"10.1016\/j.cancergen.2016.09.007_bib0015","doi-asserted-by":"crossref","first-page":"6760","DOI":"10.1182\/blood-2011-08-373902","article-title":"Impact of additional cytogenetic aberrations at diagnosis on prognosis of CML: long-term observation of 1151 patients from the randomized CML Study IV","volume":"118","author":"Fabarius","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.cancergen.2016.09.007_bib0020","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1182\/blood-2011-10-384651","article-title":"Additional chromosomal abnormalities in Philadelphia-positive clone: adverse prognostic influence on frontline imatinib therapy: a GIMEMA Working Party on CML analysis","volume":"120","author":"Luatti","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.cancergen.2016.09.007_bib0025","first-page":"591","article-title":"bcl-1 rearrangement. Frequency and clinical significance among B-cell chronic lymphocytic leukemias and non-Hodgkin's lymphomas","volume":"138","author":"Athan","year":"1991","journal-title":"Am J Pathol"},{"key":"10.1016\/j.cancergen.2016.09.007_bib0030","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/0165-4608(94)00191-X","article-title":"Translocation 11;14 in newly diagnosed chronic myelogenous leukemia","volume":"81","author":"Magdalinski","year":"1995","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.cancergen.2016.09.007_bib0035","first-page":"502","article-title":"The impact of additional cytogenetic abnormalities at diagnosis and during therapy with tyrosine kinase inhibitors in chronic myeloid leukaemia","volume":"8","author":"Crisan","year":"2015","journal-title":"J Med Life"},{"key":"10.1016\/j.cancergen.2016.09.007_bib0040","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/0165-4608(90)90030-E","article-title":"Cytogenetic peculiarities in chronic myelogenous leukemia","volume":"47","author":"Hild","year":"1990","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.cancergen.2016.09.007_bib0045","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1002\/ajh.24094","article-title":"Mantle cell lymphoma: 2015 update on diagnosis, risk-stratification, and clinical management","volume":"90","author":"Vose","year":"2015","journal-title":"Am J Hematol"},{"key":"10.1016\/j.cancergen.2016.09.007_bib0050","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.cancergen.2015.03.007","article-title":"Acquisition of a t(11;14)(q13;q32) in clonal evolution in a follicular lymphoma with a t(14;18)(q32;q21) and t(3;22)(q27;q11.2)","volume":"208","author":"Koduru","year":"2015","journal-title":"Cancer Genet"},{"key":"10.1016\/j.cancergen.2016.09.007_bib0055","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1309\/AJCPUIDW2CPTA1JA","article-title":"Cyclin D1-positive diffuse large B-cell lymphoma with IGH-CCND1 translocation and BCL6 rearrangement. A report of two cases","volume":"143","author":"Al-Kawaaz","year":"2015","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.cancergen.2016.09.007_bib0060","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/ejh.12119","article-title":"Acquisition of t(11;14) in a patient with chronic lymphocytic leukemia carrying both t(14;19)(q32;q13.1) and +12","volume":"91","author":"Nishida","year":"2013","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.cancergen.2016.09.007_bib0065","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.cancergencyto.2009.08.013","article-title":"Detection of the t(11;14)(q13;q32) without CCND1\/IGH fusion in a case of acute myeloid leukemia","volume":"195","author":"Tarsitano","year":"2009","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.cancergen.2016.09.007_bib0070","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1182\/blood.V88.2.674.bloodjournal882674","article-title":"Dysregulation of cyclin D1 by translocation into an IgH \u03b3 switch region in two multiple myeloma cell lines","volume":"88","author":"Chesi","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.cancergen.2016.09.007_bib0075","first-page":"2253","article-title":"Significance of cyclin D1 overexpression for the diagnosis of mantle cell lymphoma: a clinicopathologic comparison of cyclin D1-positive MCL and cyclin D1-negative MCL-like B-cell lymphoma","volume":"95","author":"Yatabe","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.cancergen.2016.09.007_bib0080","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.cellsig.2007.10.018","article-title":"GSK-3beta regulates cyclin D1 expression: a new target for chemotherapy","volume":"20","author":"Takahashi-Yanaga","year":"2008","journal-title":"Cell Signal"},{"key":"10.1016\/j.cancergen.2016.09.007_bib0085","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1182\/blood-2011-06-361261","article-title":"Targeting of GSK3\u03b2 promotes imatinib-mediated apoptosis in quiescent CD34+ chronic myeloid leukemia progenitors, preserving normal stem cells","volume":"119","author":"Reddiconto","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.cancergen.2016.09.007_bib0090","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1158\/1535-7163.MCT-09-1212","article-title":"Targeted inhibition of SRC kinase signaling attenuates pancreatic tumorigenesis","volume":"9","author":"Nagaraj","year":"2010","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.cancergen.2016.09.007_bib0095","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.3324\/haematol.12793","article-title":"Centrosome aberrations and G1 phase arrest after in vitro and in vivo treatment with the SRC\/ABL inhibitor dasatinib","volume":"93","author":"Fabarius","year":"2008","journal-title":"Haematologica"}],"container-title":["Cancer Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210776216302447?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210776216302447?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:41:31Z","timestamp":1761896491000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2210776216302447"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":18,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["S2210776216302447"],"URL":"https:\/\/doi.org\/10.1016\/j.cancergen.2016.09.007","relation":{},"ISSN":["2210-7762"],"issn-type":[{"type":"print","value":"2210-7762"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chronic myelogenous leukemia with acquired t(11;14)(q13;q32) CCND1-IGH: A case report and literature review","name":"articletitle","label":"Article Title"},{"value":"Cancer Genetics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cancergen.2016.09.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}